The USA spends 3.5% of its whole health care budget dealing with the consequences of childhood exposure to environmental toxic chemicals, researchers from Mount Sinai School of Medicine revealed in the journal Health Affairs. The authors stress that new laws are needed to address the testing of new chemicals as well as those already in use.

Leonardo Trasande, MD, and team set out to determine what the national toll might be for childhood exposure to toxic chemicals, and their impact on lead poisoning, autism, asthma, ADHD (attention deficit hyperactivity disorder), and cancer rates among children. They also calculated the annual direct medical care costs, as well as other (indirect) costs, such as productivity loss by parents caring for their children, etc.

The authors found that: $76.6 billion is spent annually dealing with the consequences of childhood exposure to environmental chemicals This represents 3.5% of the country's health costs in 2008 $50.9 billion was spent dealing with lead poisoning $7.9 billion was spent on autism $5.4 billion was spent on intellectual disability $5.1 billion was spent on mercury pollution $5 billion was spent on ADHD $2.2 billion was spent on asthma $95 million was spent on childhood cancer Dr. Trasande said:

"Our findings show that, despite previous efforts to curb their use, toxic chemicals have a major impact on health care costs and childhood morbidity. New policy mandates are necessary to reduce the burden of disease associated with environmental toxins. The prevalence of chronic childhood conditions and costs associated with them may continue to rise if this issue is not addressed."

The team examined a 1997 study which revealed a yearly cost of $54.9 billion for childhood diseases linked to environmental toxins in the USA. This earlier study had been carried out by Dr. Philip J. Landrigan, MD, currently Dean for Global Health, and Professor and Chair of Preventive Medicine, and Professor of Pediatrics, at Mount Sinai School of Medicine.

Although lead exposure and asthma related costs had dropped, new chemicals and diseases likely caused by their arrival, such as ADHD have increased the overall costs of childhood disease.

In another report in the same journal, Dr. Landrigan from Mount Sinai and Lynn R. Goldman, MD, from George Washington University, propose the following three-pronged approach to bring down the burden of disease and reduce the impact of toxic chemicals in the environment: Carefully analyze and evaluate those chemicals that are already on the market for possible toxicity, starting with the most widely used ones, using modern, efficient toxicity testing technologies Test and evaluate any new chemical for toxicity before it is allowed to enter the market. Maintain strict and well-enforced regulations on these chemicals. More funds should be directed towards epidemiologic monitoring so that scientists and health care professionals are better able to understand and prevent some of the impacts that chemicals have on children. Dr. Landrigan said:

"Implementing these proposals would have a significant impact in preventing childhood disease and reducing health costs. Scant legislation has been passed to reduce the risks associated with childhood exposure to toxic chemicals in the environment. Even though only six chemicals have been banned, we have seen dramatic benefits from that action alone. The removal of lead from gasoline and paint is an example of the importance of this type of regulation."

In another report in the same journal, Dr. Perry Sheffield set out to determine whether there might be a link between air pollution and childhood respiratory illness, and the subsequent health care costs.

Dr. Sheffield and colleagues gathered hospitalization data between 1999 and 2007 for infants aged between 1 and 12 months who developed bronchiolitis - an asthma-like viral lung infection. They monitored the air quality around the hospitals where the infants had been hospitalized. There was a clear link between total charges and costs for infant bronchiolitis hospitalizations and levels of fine particulate matter pollutant surrounding those hospitals.

There was a $127 average increase per infant in bronchiolitis hospitalization costs as air pollutant levels increased. They worked out that US health care costs could be reduced by $15 million per year if fine particulate levels went down by just 7%.

Dr. Sheffield said:

"While more research is required to understand the full effect of air pollutants on infectious disease severity and health care costs, our findings are indicative of the tremendous impact new legislation on air quality control standards could have on the health of our children."

"Reducing The Staggering Costs Of Environmental Disease In Children, Estimated At $76.6 Billion In 2008"
Leonardo Trasande, and Yinghua Liu
Health Aff May 2011 10.1377/hlthaff.2010.1239



Tag Cloud

Buy Actonel Without Prescription
Buy Adefovir Without Prescription
Buy Allopurinol Without Prescription
Buy Antabuse Without Prescription
Buy Arava Without Prescription
Buy Armour Without Prescription
Buy Atarax Without Prescription
Buy Azathioprine Without Prescription
Buy Bayer ASA Aspirin Without Prescription
Buy CellCept Without Prescription
Buy Colchicine Without Prescription
Buy Cyklokapron Without Prescription
Buy Cystone Without Prescription
Buy Detrol Without Prescription
Buy Dexamethasone Without Prescription
Buy Diamox Without Prescription
Buy Diltiazem Cream Without Prescription
Buy Ditropan Without Prescription
Buy Epogen Without Prescription
Buy Fosamax Without Prescription
Buy HIV Test Without Prescription
Buy Human Growth Hormone Without Prescription
Buy Kenalog Without Prescription
Buy Meclizine Without Prescription
Buy Mestinon Without Prescription
Buy Motilium Without Prescription
Buy Naltrexone Without Prescription
Buy Nimotop Without Prescription
Buy Persantine Without Prescription
Buy Potassium Citrate Without Prescription
Buy Prednisolone Without Prescription
Buy Probenecid Without Prescription
Buy Prograf Without Prescription
Buy Pyridium Without Prescription
Buy Reglan Without Prescription
Buy Rocaltrol Without Prescription
Buy Rogaine Without Prescription
Buy Synthroid Without Prescription
Buy Triamcinolone Without Prescription
Buy Urispas Without Prescription
Buy Urivoid Without Prescription
Buy Ursodiol Without Prescription
Buy Vasodilan Without Prescription
Buy Vesicare Without Prescription
Buy Zofran Without Prescription
Buy Anti Flu Face Mask Without Prescription
Buy Anti-Bacterial Face Mask Without Prescription
Buy Atripla Without Prescription
Buy Combivir Without Prescription
Buy Didanosine Without Prescription
Buy Epivir Without Prescription
Buy Famvir Without Prescription
Buy Nevirapine Without Prescription
Buy Retrovir Without Prescription
Buy Ribavirin Without Prescription
Buy Stavudine Without Prescription
Buy Sustiva Without Prescription
Buy Truvada Without Prescription
Buy Valtrex Without Prescription
Buy Zovirax Without Prescription